BiomX Inc. (HLSQ)
NYSEAMERICAN: HLSQ · Real-Time Price · USD
1.430
-0.420 (-22.70%)
Sep 11, 2026, 11:29 AM EDT - Market open
BiomX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Selling, General & Admin | 13.81 | 11.74 | 14.79 | 9.56 | 10.56 | 12.28 |
Research & Development | 8.73 | 19.18 | 20.76 | 15.79 | 15.14 | 21.67 |
Amortization of Goodwill & Intangibles | - | - | - | - | 1.52 | 1.52 |
Operating Expenses | 22.54 | 30.92 | 35.55 | 25.35 | 27.22 | 35.46 |
Operating Income | -22.44 | -30.92 | -35.55 | -25.35 | -27.22 | -35.46 |
Interest Expense | - | -0.02 | -0.87 | -2.4 | -2.07 | -0.7 |
Interest & Investment Income | 0.69 | 0.46 | 1.05 | 1.12 | 0.46 | 0.09 |
Currency Exchange Gain (Loss) | -0.22 | -0.22 | -0.05 | 0.18 | 0.45 | -0.08 |
Other Non Operating Income (Expenses) | -14.83 | 5.05 | 26.69 | 0.3 | 0.12 | -0.01 |
EBT Excluding Unusual Items | -36.8 | -25.65 | -8.74 | -26.15 | -28.25 | -36.16 |
Merger & Restructuring Charges | - | - | -0.89 | - | - | - |
Impairment of Goodwill | - | - | -0.8 | - | - | - |
Asset Writedown | -1.65 | -1.65 | -4.05 | - | - | - |
Other Unusual Items | 2.95 | 2.95 | - | - | - | - |
Pretax Income | -45.49 | -36.19 | -17.71 | -26.15 | -28.25 | -36.16 |
Income Tax Expense | 0 | 0.01 | 0.01 | 0.02 | 0.07 | 0.07 |
Net Income | -45.42 | -36.2 | -17.73 | -26.17 | -28.32 | -36.23 |
Preferred Dividends & Other Adjustments | 0.09 | - | - | - | - | - |
Net Income to Common | -45.5 | -36.2 | -17.73 | -26.17 | -28.32 | -36.23 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change | 235.31% | 115.25% | 180.48% | 71.93% | 14.79% | 12.77% |
EPS (Basic) | -109.54 | -221.94 | -253.65 | -968.65 | -1802.14 | -2646.55 |
EPS (Diluted) | -109.54 | -221.94 | -583.11 | -969.00 | -1802.14 | -2646.55 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -18.16 | -26.39 | -37.01 | -21.34 | -29.2 | -31.26 |
Free Cash Flow Per Share | -43.71 | -161.81 | -488.41 | -789.75 | -1858.59 | -2283.39 |
EBITDA | -20.04 | -28 | -33.75 | -24.48 | -26.22 | -34.42 |
D&A For EBITDA | 2.4 | 2.92 | 1.8 | 0.87 | 1 | 1.05 |
EBIT | -22.44 | -30.92 | -35.55 | -25.35 | -27.22 | -35.46 |